Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PREselection of Patients at Risk for COgnitive DEcline After Radiotherapy Using Advanced MRI

NCT04638478 is registered in ClinicalTrials.gov with Maastricht Radiation Oncology as lead sponsor.

NCT NCT04638478
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04638478 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PREselection of Patients at Risk for COgnitive DEcline After Radiotherapy Using Advanced MRI
Lead sponsor
Maastricht Radiation Oncology
Phase
Observational
Overall status
Active, not recruiting
Start date
April 8, 2021
Completion date
May 1, 2029
Enrollment
67 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

meningioma